Thermo Fisher Scientific to Acquire CMO Patheon

By | May 18, 2017

The boards of directors at Thermo Fisher Scientific and Patheon have approved Thermo Fisher’s acquisition of Patheon for $35.00 per share in cash. The transaction represents a purchase price of approximately $7.2 billion, which includes the assumption of approximately $2.0 billion of net debt. Patheon provides contract development and manufacturing services, primarily at facilities in… Read More »

First New Treatment for ALS in More Than 20 Years Approved by FDA

By | May 11, 2017

MT Pharma America announced that the FDA has granted approval of Radicava (edaravone) to treat amyotrophic lateral sclerosis (ALS). ALS is a rapidly progressive neurodegenerative disease – the majority of patients die within two to five years of diagnosis. An estimated 6,000 Americans are diagnosed each year with ALS, an incurable disease that affects the… Read More »

Magenta Therapeutics Adds $50 Million for Stem Cell Development

By | May 11, 2017

Cambridge-based Magenta Therapeutics, a biotech company developing therapies to improve and expand the use of curative stem cell transplantation, has announced completion of a $50 million Series B financing; in-licensing of a clinical-stage program from Novartis to support the use of stem cell transplantation in a variety of disease settings; and a strategic partnership with… Read More »

Student Poster Contest Winners Earn $500 and Free Trip to ISPE Annual Meeting!

By | May 11, 2017

The Chapter held its annual Student Poster Contest at WPI on April 13th in conjunction with the Chapter’s monthly educational program on single use technologies. Students set up their posters in WPI’s pilot manufacturing facility where they had the opportunity to see state-of-the-art equipment in operation while meeting and networking with over 50 ISPE professionals.… Read More »